猸愶笍猸愶笍猸愶笍猸愶笍猸愶笍 "A total no brainer"

猸愶笍猸愶笍猸愶笍猸愶笍猸愶笍 "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Lapatinib In Chemotherapy-Naive Or Metastatic Breast Cancer

Official Title: A Phase II, Open-Label, Randomized, Parallel-Group Multicenter Trial Comparing Two Schedules of GW572016 as First-Line Monotherapy in Patients With Advanced or Metastatic Breast Cancer

Study ID: NCT00089999

Interventions

Lapatinib

Study Description

Brief Summary: This phase II study will evaluate and compare the efficacy and tolerability of two dose schedules (1500 mg QD and 500 mg BID) of oral Lapatinib as treatment for patients with advanced or metastatic breast cancer.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

GSK Investigational Site, Hollywood, Florida, United States

GSK Investigational Site, Santiago, Regi贸n Metro De Santiago, Chile

GSK Investigational Site, Santiago, Regi贸n Metro De Santiago, Chile

GSK Investigational Site, Santiago, Regi贸n Metro De Santiago, Chile

GSK Investigational Site, Pokfulam, , Hong Kong

GSK Investigational Site, Delhi, , India

GSK Investigational Site, Hyderabad, Andhra Pradesh, , India

GSK Investigational Site, Pune, , India

GSK Investigational Site, Bandar Tun Razak, Cheras, , Malaysia

GSK Investigational Site, Kubang Kerian, , Malaysia

GSK Investigational Site, Tanjong Bungah, , Malaysia

GSK Investigational Site, Tanjong Bungah, , Malaysia

GSK Investigational Site, Ixtaltepec / Espinal, Oaxaca, Mexico

GSK Investigational Site, Merida, Yucat谩n, Mexico

GSK Investigational Site, Mexico, , Mexico

GSK Investigational Site, Karachi, , Pakistan

GSK Investigational Site, Karachi, , Pakistan

GSK Investigational Site, Karachi, , Pakistan

GSK Investigational Site, Lahore, , Pakistan

GSK Investigational Site, Rawalpindi, , Pakistan

GSK Investigational Site, Callao, , Peru

GSK Investigational Site, Lima, , Peru

GSK Investigational Site, Lima, , Peru

GSK Investigational Site, Lima, , Peru

GSK Investigational Site, Bydogoszcz, , Poland

GSK Investigational Site, Krakow, , Poland

GSK Investigational Site, Olsztyn, , Poland

GSK Investigational Site, Singapore, , Singapore

GSK Investigational Site, Singapore, , Singapore

GSK Investigational Site, Taipei, , Taiwan

GSK Investigational Site, Taipei, , Taiwan

Contact Details

Name: GSK Clinical Trials

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: